A small nonhuman primate model for filovirus-induced disease
- 1 November 2011
- Vol. 420 (2), 117-124
- https://doi.org/10.1016/j.virol.2011.08.022
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NIH) for Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (U54 AI057156, U54 AI57168)
- NIH laboratory construction (C06 RR12087)
- Southwest Foundation Forum
- New England Primate Center (P51 RR00168-45)
- Southwest National Primate Research Center (P51 RR013986)
This publication has 44 references indexed in Scilit:
- Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell culturesVirology Journal, 2011
- The Marmoset Model of GB Virus B Infections: Adaptation to Host Phenotypic VariationJournal of Virology, 2009
- Disease modeling for Ebola and Marburg virusesDisease Models & Mechanisms, 2009
- Protection against lethal challenge by Ebola virus-like particles produced in insect cellsVirology, 2008
- Common Marmosets (Callithrix jacchus) as a Nonhuman Primate Model To Assess the Virulence of Eastern Equine Encephalitis Virus StrainsJournal of Virology, 2008
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primatesVaccine, 2008
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman PrimatesJournal of Virology, 2008
- Pyrosequencing as a method for SNP identification in the rhesus macaque (Macaca mulatta)BMC Genomics, 2008
- Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target TissuesJournal of Virology, 2007
- A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunityVaccine, 2007